Frequency Therapeutics FREQ

$ 14.98 0.0%

Quarterly report 2024-Q3
added 11-12-2024

Frequency Therapeutics Balance Sheet 2011-2024 | FREQ

Annual Balance Sheet Frequency Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-133 M	-33.2 M	-49 M	-175 M	-200 M	-42.2 M	-17.9 M	-	-	-	-	-	-
Long Term Debt	31.2 M	209 K	28.9 M	15 M	-	-	-	-	-	-	-	-	-
Long Term Debt Current	1.99 M	2.92 M	1.75 M	397 K	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	45.6 M	3.08 M	89.1 M	47.2 M	-	-	-	-	-	-
Total Current Liabilities	19.5 M	8.7 M	11.4 M	26.6 M	52.8 M	-	-	-	-	-	-	-	-
Total Liabilities	51.8 M	8.91 M	54.5 M	72.2 M	55.9 M	92.8 M	49.4 M	-	-	-	-	-	-
Deferred Revenue	-	-	-	14.1 M	48.2 M	-	-	-	-	-	-	-	-
Retained Earnings	-183 M	-102 M	-180 M	-95.4 M	-68.9 M	-49.1 M	-29.9 M	-	-	-	-	-	-
Total Assets	222 M	73.7 M	185 M	265 M	223 M	44.5 M	19.8 M	-	-	-	-	-	-
Cash and Cash Equivalents	166 M	36.3 M	79.6 M	220 M	200 M	-	-	-	-	-	-	-	-
Book Value	170 M	64.8 M	131 M	192 M	167 M	-48.3 M	-29.6 M	-	-	-	-	-	-
Total Shareholders Equity	170 M	-99 M	131 M	192 M	167 M	-48.3 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Frequency Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	41.8 M	38 M	34.7 M	31.2 M	-	25.6 M	26.2 M	26.8 M	27.3 M	27.8 M	28.4 M	28.9 M	29.3 M	29.8 M	30.2 M	30.6 M	30.6 M	30.6 M	30.6 M	180 K	180 K	180 K	180 K	349 K	349 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	63.9 M	51.5 M	46.6 M	51.8 M	9.61 M	34 M	48.3 M	52 M	54 M	53.8 M	52.3 M	54.5 M	55.1 M	54.2 M	64.1 M	72.2 M	72.2 M	72.2 M	72.2 M	55.9 M	55.9 M	55.9 M	55.9 M	4.12 M	4.12 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	2.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	9.42 M	14.1 M	14.1 M	14.1 M	14.1 M	48.2 M	48.2 M	48.2 M	48.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-245 M	-224 M	-203 M	-183 M	-304 M	-292 M	-281 M	-262 M	-244 M	-225 M	-203 M	-180 M	-159 M	-133 M	-116 M	-95.4 M	-95.4 M	-95.4 M	-95.4 M	-68.9 M	-68.9 M	-68.9 M	-68.9 M	-49.1 M	-49.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	244 M	250 M	198 M	222 M	46.3 M	79.4 M	102 M	121 M	136 M	150 M	165 M	185 M	202 M	220 M	242 M	265 M	265 M	265 M	265 M	223 M	223 M	223 M	223 M	44.5 M	44.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	63.2 M	91.2 M	139 M	166 M	41.7 M	39.7 M	40.9 M	52 M	43.8 M	42.4 M	49.8 M	79.6 M	112 M	135 M	169 M	220 M	220 M	220 M	220 M	200 M	200 M	200 M	200 M	42.2 M	42.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	180 M	198 M	151 M	170 M	36.7 M	45.4 M	53.2 M	69.2 M	82 M	95.9 M	113 M	131 M	147 M	166 M	177 M	192 M	192 M	192 M	192 M	167 M	167 M	167 M	167 M	40.4 M	40.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	180 M	198 M	151 M	170 M	-153 M	-135 M	-118 M	69.2 M	82 M	95.9 M	113 M	131 M	147 M	166 M	177 M	192 M	192 M	192 M	192 M	167 M	167 M	167 M	167 M	-48.3 M	-48.3 M	-38 M	-	-29.6 M	-	-	-	-9.66 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency